Abstract:Non-alcoholic fatty liver disease (NAFLD) is affecting up to one-third of the general population in western countries. While the major cause of NAFLD is related to an unhealthy lifestyle, recent evidence has shown a role of chemical exposure in the induction and progression of NAFLD. Perfluorooctanoate (PFOA) is a ubiquitous environmental contaminant that exerts its hepatotoxicity mainly through the activation of peroxisome proliferator-activated receptor α (PPARα). We examined how PFOA might affect the progression of NAFLD and whether a preexisting fatty liver intensified or alleviated the effects of PFOA in the livers. As such, male C57BL/6 mice were fed with a low-fat control diet (CD) or a high fat diet (HFD) for 16 weeks to model normal or steatotic livers, respectively. Mice were then administered with PFOA (1mg/kg/d) by oral gavage for an additional 2, 8, and 16 weeks. Dietary treatment was continued throughout the whole study. We found HFD induced hepatic steatosis, lobular inflammation, and progressive fibrosis in mice. As expected, PFOA activated PPARα, constitutive androstane receptor (CAR) and pregnane X receptor (PXR), regardless of the diet. Gene expression analysis showed the interactions between HFD and PFOA on hepatic nuclear receptors were time-dependent. Hepatocytes growth as measured by DNA synthesis and cell growth genes induced by PFOA were exacerbated in the HFD group after 2 weeks, along with the enhanced activation of PPARα. In contrast, PFOA decreased the severity of hepatic steatosis. In HFD-fed mice, the hepatic triglyceride levels were reduced to 75%, 47%, and 40%, after 2, 8, and 16 weeks of PFOA treatment, respectively, compared to vehicle controls. Transcriptomic analysis showed the preexisting NAFLD enhanced PFOA related lipid oxidation pathways in mice. HFD induced hepatic fibrosis as measured by collagen staining and fibrosis gene markers were also attenuated by PFOA. Taken together, this study demonstrated that the preexisting NAFLD might impact on many biological effects induced by PFOA and thus need to be carefully considered as a factor in risk assessment.

Involvement Of Nrf2 In Perfluorooctanoic Acid-Induced Testicular Damage In Male Mice

Bisphenol A Exposure Induces Testicular Oxidative Damage Via FTO/m6A/Nrf2 Axis During Postnatal Development in Mice.

Proteomic Analysis of Mouse Testis Reveals Perfluorooctanoic Acid-Induced Reproductive Dysfunction Via Direct Disturbance of Testicular Steroidogenic Machinery

Perfluorooctanoic Acid Exposure Alters Polyunsaturated Fatty Acid Composition, Induces Oxidative Stress and Activates the AKT/AMPK Pathway in Mouse Epididymis

Perfluorooctane sulfonate-induced testicular toxicity and differential testicular expression of estrogen receptor in male mice.

Involvement of Oxidative Stress and Inflammation in Liver Injury Caused by Perfluorooctanoic Acid Exposure in Mice

Perfluorooctanoic Acid Disrupts the Blood–testis Barrier and Activates the TNFα/p38 MAPK Signaling Pathway in Vivo and in Vitro

Perfluorooctanoic Acid Induces Cytotoxicity in Spermatogonial GC-1 Cells.

Effects of maternal exposure to PFOA on testes of male offspring mice

Perfluorooctanoic acid induces Leydig cell injury via inhibition of autophagosomes formation and activation of endoplasmic reticulum stress

Possible mechanisms for adverse effects on zebrafish sperm and testes associated with low-level chronic PFOA exposure

Male reproductive toxicity of perfluorooctanoate (PFOA): Rodent studies

1α,25‐dihydroxyvitamin D3 supplementation alleviates perfluorooctanesulfonate acid‐induced reproductive injury in male mice: Modulation of Nrf2 mediated oxidative stress response

Attenuation of Perfluorooctanoic Acid-Induced Testicular Oxidative Stress and Apoptosis by Quercetin in Mice

Proteomic analysis for testis of rats chronically exposed to perfluorododecanoic acid.

Male reproductive toxicity involved in spermatogenesis induced by perfluorooctane sulfonate and perfluorooctanoic acid in Caenorhabditis elegans

The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.

Effects of Perfluorooctanoic Acid on Gut Microbiota and Microbial Metabolites in C57BL/6J Mice

Perfluorooctanoic Acid Affects Endocytosis Involving Clathrin Light Chain A and Microrna-133B-3p in Mouse Testes.

Exposure to Perfluorooctanoic Acid Induces Cognitive Deficits Via Altering Gut Microbiota Composition, Impairing Intestinal Barrier Integrity, and Causing Inflammation in Gut and Brain.

Toxicity Assessment of Perfluorooctane Sulfonate Using Acute and Subchronic Male C57BL/6J Mouse Models.